Login to Your Account



Washington Roundup

No Guidance, But the FDA is Studying Social Media Impact

By Mari Serebrov
Washington Editor

Tuesday, January 17, 2012
WASHINGTON – In yet another signal that it's seriously considering drugmakers' use of social media, the FDA plans to survey health care professionals on the impact direct-to-consumer (DTC) drug promotion, whether online or in traditional media, has on their practice.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription